✦ LIBER ✦

Short- and long-term effects of therapy with interferon-α and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

✍ Scribed by M. Homoncik; A. Ferlitsch; P. Ferenci; E. Formann; B. Jilma; A. Gangl; S. Panzer; M. Peck-Radosavljevic

Book ID: 108603908
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 200 KB
Volume: 21
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2004.02305.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective study of bone mineral densit

Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy

✍ W. P. Hofmann; B. Kronenberger; J. Bojunga; B. Stamm; E. Herrmann; A. Bücker; U 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Prediction of nonSVR to therapy with peg

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Loss of serum HCV RNA at week 4 of inter

Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C

✍ Etsuro Orito; Masashi Mizokami; Kaoru Suzuki; Ken-Ichi Ohba; Tomoyoshi Ohno; Mas 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

## Abstract To determine the virological factors associated with a favorable long‐term response to interferon‐α (IFN) therapy in chronic hepatitis C virus (HCV) infection, 61 Japanese patients with chronic HCV infection were treated with IFN for 24 weeks (780 million units in total) and followed fo

Could a loss of memory T cells limit res

Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-α and ribavirin therapy?

✍ S. Lee; T. Hammond; M. W. Watson; J. P. Flexman; W. Cheng; S. Fernandez; P. Pric 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB